肺动脉高压患者日常体力活动的加速度计多中心纵向研究
结果显示日常活动随时间下降,与WHO功能分级III级、右心室功能较差及结缔组织病相关PAH有关;较低基线活动与HRQoL、6MWD、股骨/髋部BMD较差及临床恶化风险增加相关(每少活动1小时/周,HR 1.06,P<.01)。
要点
- 加速度计测量的日常活动可反映PAH疾病严重程度和功能状态。
- 较低基线活动与临床恶化风险增加相关(HR 1.06/小时/周,P<.01)。
- 日常活动可能作为传统评估的患者中心性动态补充指标。
核心结论
- 加速度计衍生的体力活动反映PAH疾病严重程度,并与HRQoL、BMD和临床恶化相关。
- 这些指标可能为传统评估提供动态、以患者为中心的补充。
研究设计与样本
- PHANTOM多中心随机对照试验(阿那曲唑治疗PAH)的纵向分析,在美国7个中心纳入男性及绝经后女性PAH患者。
主要发现
- 活动随时间下降,且在WHO功能分级III级、右心室功能较差和结缔组织病相关PAH患者中更低。
- 较低日常活动与较差HRQoL、较差基线6MWD和较差基线股骨/髋部BMD相关。
- 较低基线活动与临床恶化风险增加相关(每少活动1小时/周,HR 1.06;P<.01)。
关键数值与推荐
- 临床结局包括6MWD、HRQoL(emPHasis-10和SF-36)、BMD及至临床恶化时间(住院、治疗升级或死亡)。
- 采用混合效应模型评估活动与人口学、临床、超声心动图和環境变量的关联;Cox模型分析活动与临床恶化时间的关系。
临床怎么用
- 在PAH评估中可考虑使用加速度计监测日常体力活动,作为传统功能评估的补充。
- 关注活动水平较低的患者,其HRQoL、运动能力和骨密度可能更差,临床恶化风险更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary arterial hypertension (PAH) is a progressive disease associated with high morbidity and mortality. Traditional assessments such as the 6-minute walk distance (6MWD) may not adequately capture daily physical activity or patient experience in real-world settings. RESEARCH QUESTION: Among patients with PAH, do accelerometer-derived measures of daily physical activity reflect disease severity, functional status, and outcomes over time? STUDY DESIGN AND METHODS: Pulmonary Hypertension and Anastrozole (PHANTOM), a multicenter randomized controlled trial of anastrozole in PAH, enrolled male patients and postmenopausal female patients with PAH at 7 centers in the United States. Patients completed 4 in-person study visits over 12 months. Participants wore hip-based accelerometers for 7 days at each visit. Mixed-effects models assessed associations between daily physical activity and demographic, clinical, echocardiographic, and environmental variables. Clinical outcomes included: 6MWD; health-related quality of life (HRQoL), assessed by using the emPHasis-10 questionnaire and the 36-item Short Form Health Survey; bone mineral density (BMD); and time to clinical worsening (hospitalization, treatment escalation, or death). Cox models were used to examine associations between activity and time to clinical worsening. RESULTS: Eighty-four participants were enrolled (mean age 61 years; 67% female). Device adherence was high across visits. Activity declined over time and was lower in patients with World Health Organization functional class III, worse right ventricular function, and connective tissue disease-associated PAH. Lower daily activity was associated with worse HRQoL, worse baseline 6MWD, and worse baseline femoral/hip BMD. Lower baseline activity was associated with increased risk of clinical worsening (hazard ratio, 1.06 per hour/week less active; P < .01). INTERPRETATION: Our results suggest that accelerometer-derived physical activity reflects disease severity and is associated with HRQoL, BMD, and clinical worsening in PAH. These metrics may offer a dynamic, patient-centered complement to traditional assessments.
引用
- Minhas J, Shou H, Al-Naamani N, et al. Daily Physical Activity in Pulmonary Arterial Hypertension: Insights From a Multicenter Longitudinal Trial Using Accelerometry. Chest. 2026. PMID: 41644091. doi:10.1016/j.chest.2025.12.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。